IGF1R and cancer: A lower expression of Bcl-2 and a higher expression of IGF-1R in unclassified tumors compared to ER/PR + HER2- were thus suggested to be partly involved in the reported worse prognosis of unclassified type cancer than ER/PR + HER2- [2,4,5].